Metraipolis › archive › dc_29d43d700fcd
Combination therapy for platinum-resistant ovarian cancer: a novel at-home regimen with envafolimab, lenvatinib, and etoposide — Europe PMC PMID:40658469
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40658469
- DOI
- 10.1093/oncolo/oyaf210
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:39:03.287Z
- SHA-256 of the archived text
4fb38a07c6fc4088be3c7fc3fc8b5491a66de9f24192161bb453296f1df87375- Stable URL of this page
https://metraipolis.com/documento/dc_29d43d700fcd
How to cite
Combination therapy for platinum-resistant ovarian cancer: a novel at-home regimen with envafolimab, lenvatinib, and etoposide — Europe PMC PMID:40658469 — Europe PMC (en), https://europepmc.org/article/MED/40658469 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_29d43d700fcd (Metraipolis archive dc_29d43d700fcd, sha256 4fb38a07c6fc4088be3c7fc3fc8b5491a66de9f24192161bb453296f1df87375)
BibTeX
@misc{dc29d43d700fcd,
title = {Combination therapy for platinum-resistant ovarian cancer: a novel at-home regimen with envafolimab, lenvatinib, and etoposide — Europe PMC PMID:40658469},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40658469},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_29d43d700fcd; sha256 4fb38a07c6fc4088be3c7fc3fc8b5491a66de9f24192161bb453296f1df87375},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40658469. Agents can read the archived copy with the MCP tool read_document.